Official recall notice

FDA DrugClass IINotable

FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-

Recall date
2026-03-11
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Recommended action

What to do

N/A

Product description

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Related Recalls